Home › NDC Lookup › Ingredients › Pramipexole
📦 NDC / package directory — not a drug information page

Pramipexole NDCs, Package Codes, Strengths & Labelers

This page lists NDC package records for Pramipexole products — strengths, dosage forms, package sizes, labelers, 11-digit billing NDCs, pricing data when available, and links to each individual NDC page. It’s an NDC/package & billing directory, not a clinical drug page.

Looking for uses, warnings & side effects? Read our Pramipexole drug information page →

Key stats

18
Package NDCs
6
Products
6
Active listings
0
Discontinued
1
Labelers
6
Strengths
1
Dosage forms
0
With NADAC pricing

By strength, form & labeler

NDC products by strength
PRAMIPEXOLE DIHYDROCHLORIDE .125 m... 1
PRAMIPEXOLE DIHYDROCHLORIDE .25 mg... 1
PRAMIPEXOLE DIHYDROCHLORIDE .5 mg/... 1
PRAMIPEXOLE DIHYDROCHLORIDE .75 mg... 1
PRAMIPEXOLE DIHYDROCHLORIDE 1 mg/1 1
PRAMIPEXOLE DIHYDROCHLORIDE 1.5 mg... 1
By dosage form
TABLET 6
Top labelers
Camber Pharmaceuticals, Inc. 6

Browse records — 6 products

Drug / product Billing NDC NADAC / unit Status
PRAMIPEXOLE .125 mg/1 TABLET Camber · NDC 31722-0906-05 · 500 TABLET in 1 BOTTLE (31722-906-05) 31722-0906-05 — On market View →
PRAMIPEXOLE .25 mg/1 TABLET Camber · NDC 31722-0907-05 · 500 TABLET in 1 BOTTLE (31722-907-05) 31722-0907-05 — On market View →
PRAMIPEXOLE .5 mg/1 TABLET Camber · NDC 31722-0908-05 · 500 TABLET in 1 BOTTLE (31722-908-05) 31722-0908-05 — On market View →
PRAMIPEXOLE .75 mg/1 TABLET Camber · NDC 31722-0909-05 · 500 TABLET in 1 BOTTLE (31722-909-05) 31722-0909-05 — On market View →
PRAMIPEXOLE 1 mg/1 TABLET Camber · NDC 31722-0910-05 · 500 TABLET in 1 BOTTLE (31722-910-05) 31722-0910-05 — On market View →
PRAMIPEXOLE 1.5 mg/1 TABLET Camber · NDC 31722-0911-05 · 500 TABLET in 1 BOTTLE (31722-911-05) 31722-0911-05 — On market View →
Where does this data come from?
NDC package records, strengths, forms and labelers come from the openFDA NDC Directory; pricing is CMS NADAC. Grouped by active-ingredient name. This is package/billing reference data, not clinical drug information.